FIELD: medicine.
SUBSTANCE: inventions relate to medicine, namely to oncology, and deals with treatment of liver cancer. For this purpose 4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid or its physiologically acceptable salt in dose from 10 to 30 mg per day is introduced. Treatment is carried out in accordance with therapeutic regimen, in accordance to which continuous daily introduction for from 1 to 4 weeks is performed. After that period of medication withdrawal for from 1 to 3 weeks follows.
EFFECT: inventions ensure essential reduction of side effects, such as deep vein thrombosis, and in addition considerably improve therapeutic effect of TAC-101 in treatment of liver cancer.
4 ex
